State of the Art and Novelties in Multidisciplinary Approach to Soft Tissue and Bone Sarcomas
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 3
Special Issue Editors
Interests: orthopedic oncology
Interests: bone tumor; surgery
Interests: sarcoma; therapy
Interests: bone tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There is no current literature consensus regarding the optimal diagnostic and treatment approach to soft tissue sarcomas (STSs). Recent publications highlighted new biological aspects and deeper genetic characterization of different types of STS, up-to-date research works focused on a highly personalized medicine approach to the treatment of STS, and modern imaging techniques (e.g. PET-MRI).
In the past decade, the use of neoadjuvant and adjuvant chemotherapy, new developed immunotherapies, combined Hyperthermia with chemo-irradiation, and advances in radiation therapy techniques, like Stereotactic Body Radiation Therapy (SBRT) or the use of Artificial Intelligence to detect radio-sensitive areas of the STS, were studied but conclusive results are still debated.
The growing importance of a multidisciplinary approach of joint surgical and medical treatment of STS, involving an orthopedic surgeon, radiologist, pathologist, vascular, general, and plastic surgeon, medical oncologist, and radiation oncologist, is becoming more prominent.
The aim of the Special issue Is to provide readers with a full comprehensive data collection on up-to-date studies and treatments for defining shared guidelines and obtaining a consensus in approaches to STS.
The following types of submissions will be considered: original studies, meta-analysis and systematic reviews, clinical trial studies.
Dr. Ron Batash
Dr. Alberto Crimì
Prof. Dr. Moshe Schaffer
Prof. Dr. Pietro Ruggieri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- soft tissue sarcoma
- bone sarcoma
- treatment
- diagnosis
- radiation therapy
- chemotherapy
